Netanyahu Leads at 46% to Be Next Israeli PM
A 14-point jump in 3 days puts Netanyahu ahead despite trailing Bennett and Eisenkot on personal suitability in a May 1 Lazar Research poll.

Netanyahu Jumps to 46% Favorite for Next Israeli PM Despite a Week That Should Have Sunk Him
In the span of ten days, Benjamin Netanyahu disclosed a prostate cancer diagnosis, watched two former prime ministers announce a joint ticket against him, and received a presidential invitation to negotiate a settlement in his corruption case. Any one of these developments could plausibly crater a political career. Together, they paint the portrait of a leader under siege from his own body, the judiciary, and a newly organized opposition bloc that polls show is more personally popular than he is.
Yet prediction markets moved decisively in Netanyahu's favor. His implied probability of becoming the next Prime Minister of Israel jumped from 31% to 46% over just three days, a 14-percentage-point surge that makes him the clear frontrunner on both Polymarket (42%) and PredictIt (49%).
The divergence between public opinion polling and market pricing is stark. A May 1 poll by Lazar Research found only 41% of Israeli respondents consider Netanyahu suitable for the premiership, trailing both Naftali Bennett (46%) and Gadi Eisenkot (44%). The market, however, is pricing something those head-to-head suitability numbers don't measure: the structural machinery of Israeli coalition politics, where personal popularity and parliamentary arithmetic rarely align.
The Cancer Disclosure That Didn't Sink Netanyahu's Political Odds
On April 24, Netanyahu confirmed publicly that he had undergone prostate surgery approximately 18 months ago and more recently received radiation therapy for a small tumor at Hadassah Hospital. He characterized the condition as a "minor medical issue" and stated he delayed the announcement to avoid fueling propaganda during military operations against Iran.
The framing matters. Netanyahu positioned the disclosure as an act of wartime responsibility, not vulnerability. His physicians described the cancer as caught early and successfully treated. He has maintained his full public schedule since the announcement, offering no visible evidence of incapacitation. Markets appear to have processed the news as medically resolved rather than politically threatening.
There may be a secondary dynamic at play. Israeli political history offers limited precedent for health disclosures harming incumbents. The exception, Ariel Sharon's 2006 stroke, involved sudden incapacitation rather than a controlled announcement of a treatable condition. Netanyahu's deliberate framing as a survivor rather than a patient may have paradoxically reinforced perceptions of durability among his political base.
Corruption Trial, Coalition Math, and Why Markets Are Betting on Netanyahu Anyway
The corruption case is the longest-running threat to Netanyahu's tenure, yet it has coexisted with his premiership for years without forcing his departure. President Isaac Herzog's April 28 invitation for Netanyahu and prosecutors to negotiate a settlement may have actually boosted market confidence. A negotiated resolution, particularly one backed by Trump's public calls for a pardon (reported by Axios on April 29), signals to bettors that the legal threat may be winding down rather than escalating.
The deeper explanation lies in Israel's fragmented parliamentary system. Likud projects between 27 and 31 Knesset seats, consistently the largest single bloc. The opposition holds a collective 61-seat majority in current polls, but forming that majority into a governing coalition requires agreement among ideologically disparate factions. Netanyahu's path to power requires fewer compromises than his opponents' path requires alliances.
The Bennett-Lapid "Beyachad" alliance, announced April 28, merges a right-wing former PM with a centrist whose party has collapsed to just 5 projected seats. Their combined platform of mandatory military service and PM term limits appeals to secular Israel but alienates ultra-Orthodox parties whose support is essential in any coalition. Markets may be reading the alliance as a sign of opposition desperation rather than opposition strength.
The Case Against Netanyahu: Why 46% Might Be Too High
The strongest counter-argument is simple: the opposition bloc holds 61 seats to Netanyahu's right-wing bloc's 49. If October's election produces numbers anywhere near current projections, Netanyahu cannot form a government regardless of Likud's individual seat count. Eisenkot's Yashar! party has risen to 16 projected seats, overtaking Bennett's 15. The opposition's fragmentation problem, which Netanyahu has exploited for a decade, may be genuinely resolving.
Netanyahu's personal suitability trailing Bennett by five points and Eisenkot by three points in the May 1 poll is not noise. These numbers reflect a public that has absorbed the corruption charges, the October 7 accountability questions (47% of Israelis disbelieve his account of events leading to the attack, per a Maariv poll from April 17), and the cancer news. If Bennett and Eisenkot avoid splitting the opposition vote through their alliance structure, Netanyahu's coalition math collapses.
The market at 46% implies roughly even odds. That price is defensible only if you believe Israel's coalition mechanics will prevent the opposition from unifying in practice, even if they unify in rhetoric. History favors that bet. But the Beyachad alliance represents the most credible organizational attempt to solve the opposition's coordination problem since 2021. If it holds through October, 46% will look generous.
What Resolves This Market
This contract resolves on December 31, 2026. Israel's general election is scheduled for October 2026. The most likely resolution scenarios: Netanyahu forms a coalition after the election (resolves YES), or an opposition figure assembles a majority without him (resolves NO for Netanyahu). A pre-election resignation due to health or a plea deal remains a tail risk that markets are discounting near zero.
The 7-percentage-point spread between Polymarket (42%) and PredictIt (49%) reflects different trader populations and liquidity dynamics rather than disagreement on fundamentals. Both platforms moved in the same direction on the same timeline, suggesting a genuine information update rather than platform-specific noise. The catalyst appears to be the convergence of the Herzog settlement invitation and Trump's pardon advocacy, which together suggested the corruption case may resolve favorably for Netanyahu before voters go to the polls.
Join our Discord for breaking news alerts, driven by real-time movements in prediction markets.
Free Trading Tools
View allCompare fees across Kalshi, Polymarket & PredictIt.
Find fair probabilities with the overround removed.
See if a trade has positive EV before you enter.
Convert American, decimal & implied probability.
Combined odds and payouts for multi-leg bets.
Your real take-home after fees and taxes.